CEL-SCI Corp Files 8-K on Security Holder Rights
Ticker: CVM · Form: 8-K · Filed: Nov 5, 2025 · CIK: 725363
Sentiment: neutral
Topics: 8-K, corporate-actions, financials
Related Tickers: SCI
TL;DR
CEL-SCI filed an 8-K on Oct 30, 2025, regarding security holder rights and financials.
AI Summary
CEL-SCI Corporation filed an 8-K on November 5, 2025, reporting material modifications to the rights of security holders and financial statements as of October 30, 2025. The company, previously known as Interleukin 2 Inc., is incorporated in Colorado and headquartered in Vienna, VA.
Why It Matters
This filing indicates potential changes affecting CEL-SCI Corporation's security holders and provides updated financial information, which could impact investor decisions.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting material modifications and financial statements, not indicating immediate operational or financial distress.
Key Players & Entities
- CEL-SCI Corporation (company) — Registrant
- Interleukin 2 Inc. (company) — Former company name
- October 30, 2025 (date) — Date of earliest event reported
- November 5, 2025 (date) — Filing date
- 8229 Boone Blvd. #802 Vienna, VA 22182 (address) — Principal executive offices
FAQ
What specific material modifications to the rights of security holders are being reported by CEL-SCI Corporation?
The filing indicates 'Material Modifications to Rights of Security Holders' as an item of disclosure, but the specific details of these modifications are not provided in the provided text snippet.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This indicates that updated financial information and related documents are being submitted to the SEC as of October 30, 2025.
When was CEL-SCI Corporation's earliest reported event for this 8-K filing?
The earliest event reported is dated October 30, 2025.
What was CEL-SCI Corporation's former name?
CEL-SCI Corporation was formerly known as Interleukin 2 Inc.
Where are CEL-SCI Corporation's principal executive offices located?
CEL-SCI Corporation's principal executive offices are located at 8229 Boone Blvd. #802 Vienna, VA 22182.
Filing Stats: 453 words · 2 min read · ~2 pages · Grade level 13.3 · Accepted 2025-11-05 16:31:28
Filing Documents
- cvm_8k.htm (8-K) — 24KB
- cvm_ex4.htm (EX-4) — 296KB
- 0001654954-25-012607.txt ( ) — 489KB
- cvm-20251030.xsd (EX-101.SCH) — 5KB
- cvm-20251030_lab.xml (EX-101.LAB) — 14KB
- cvm-20251030_cal.xml (EX-101.CAL) — 1KB
- cvm-20251030_pre.xml (EX-101.PRE) — 9KB
- cvm-20251030_def.xml (EX-101.DEF) — 2KB
- cvm_8k_htm.xml (XML) — 4KB
03. Material Modification to Rights of Security Holders
Item 3.03. Material Modification to Rights of Security Holders On October 30, 2025, the Board of Directors of CEL-SCI Corporation (the "Company") amended its Shareholder Rights Agreement, originally adopted on November 7, 2007, to provide that the Shareholder Rights Agreement will now expire on October 30, 2030. For a summary of the terms of the Shareholders Rights Agreement, see the section captioned "Description of Securities - Rights Agreement" in the Company's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on August 3, 2018.
01. FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits Exhibit Number Exhibit Name Description 4 Instruments Defining the Rights of Security Holders Shareholder Rights Agreement (as amended) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 5, 2025 CEL-SCI CORPORATION By: /s/ Geert Kersten Geert Kersten Chief Executive Officer 3